Ferrous sulphate dosage and efficacy
Pro Research Analysisby 
Searched over 200M research papers
Ferrous Sulphate Dosage in Iron Deficiency Anemia
Dosage Regimens: Once Daily vs. Twice Daily Ferrous Sulphate
Research comparing once daily (65 mg elemental iron) and twice daily (130 mg elemental iron) ferrous sulphate in pregnant women found both regimens to be equally effective in preventing anemia. The twice daily group had slightly higher hemoglobin levels, but also experienced more side effects, which could affect compliance. Therefore, a once daily dose is generally as effective and better tolerated for most patients in this context .
Efficacy of Ferrous Sulphate in Different Populations
Ferrous sulphate is effective in raising hemoglobin and iron stores in various groups, including children, pregnant women, and patients with chronic conditions. In children with iron deficiency anemia, both ferrous sulphate and iron polymaltose complex led to significant improvements in hemoglobin, with no significant difference in efficacy between the two . In cancer patients with mild anemia, ferrous sulphate (105 mg/day) was as effective as ferrous bisglycinate chelate in improving hemoglobin and ferritin, though the latter may have fewer gastrointestinal side effects . In heart failure patients with iron deficiency anemia, oral ferrous sulphate (200 mg three times daily) significantly improved functional capacity over 12 weeks .
Combination Therapy: Ferrous Sulphate with Vitamin C
Adding vitamin C to ferrous sulphate therapy in children resulted in greater improvements in hemoglobin, ferritin, and mean corpuscular volume compared to ferrous sulphate alone. This combination was well-tolerated and led to significant clinical improvement with minimal adverse reactions, suggesting that vitamin C may enhance the efficacy of ferrous sulphate in pediatric patients .
Comparison with Other Iron Formulations
Multiple studies have shown that ferrous sulphate is as effective as other oral iron salts (such as ferrous fumarate, ferrous ascorbate, sodium feredetate, and ferrous bisglycinate) in treating iron deficiency anemia in pregnancy, with similar rises in hemoglobin and ferritin across all groups . Reviews confirm that slow-release ferrous sulphate remains the standard treatment due to its good bioavailability, efficacy, and tolerability .
Oral vs. Intravenous Iron Therapy
While oral ferrous sulphate is effective and convenient, intravenous iron preparations (such as ferric carboxymaltose or iron sucrose) can lead to faster and greater increases in ferritin and hemoglobin, especially in cases of moderate to severe anemia or when rapid repletion is needed. However, oral therapy is generally preferred for mild to moderate anemia due to ease of administration and safety, unless adherence is an issue or rapid correction is required 6910.
Conclusion
Ferrous sulphate is a well-established, effective, and generally well-tolerated treatment for iron deficiency anemia across various populations. A once daily dose is usually sufficient and better tolerated than higher or more frequent dosing. Combination with vitamin C may further enhance efficacy, especially in children. While intravenous iron can be more effective in certain situations, oral ferrous sulphate remains the standard first-line therapy for most patients due to its proven efficacy, safety, and cost-effectiveness 1234+5 MORE.
Sources and full results
Most relevant research papers on this topic